Precision at Every Scale: Efficiency in AI-Driven De Novo Antibody Design
Hyeonjin Cha, Kyesoo Cho, Jeonghyeon Gu, Daehyeon Gwak, Seung Woo Ham, Mirim Hong, Sehan Kim, Suyeon Kim, Sohee Kwon, Changsoo Lee, Dohoon Lee, Danyeong Lee, Dohoon Lee, Jungsub Lim, Jinsung Noh, , Jinsol Yang
This paper evaluates GaluxDesign, an AI platform, for de novo antibody design, showing a 10.5% binder rate and strong performance on benchmark targets.
bioRxiv · Nov 21, 2025 · PreprintBioengineering